S1 Ep229: Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits
This month, we spoke with Glenn Short, PhD, senior vice president of Early Development at atai Life Sciences, about an under-discussed psychedelic drug: ibogaine. Although it has some daunting adverse...
8 Sep 202318min
S1 Ep225: Public Health Matters - Current Issues in Oncology Space
On this episode of Public Health Matters, Christina Madison, PharmD, FCCP, AAHIVP, spoke with Ryan Haumschild, PharmD, MS, MBA, to discuss current issues in oncology, including drug shortages and pati...
7 Sep 202332min
S1 Ep228: Pharmacy Focus: Policy Edition - Michigan Pharmacists' New Authority in Vaccination and Testing
In this episode of Pharmacy Focus: Policy Edition, we delve into the significant developments brought about by Michigan Senate Bill 219. The bill marks a pivotal moment for pharmacists in the state as...
5 Sep 20237min
S1 Ep227: Pharmacy Focus: Turning the Tide of the Obesity Epidemic
In this limited series, we speak with experts to understand the new frontier of anti-obesity drugs, as well as concerns and questions that still remain.
30 Aug 202333min
S1 Ep224: Dangers of Drug Diversion for Health Care Professionals
In this week's episode of Pharmacy Focus, Tom Knight, founder and CEO of Invistics, now part of Wolters Kluwer, discusses the dangers of drug diversion and how this could negatively impact affect pati...
25 Aug 202314min
S1 Ep223: Independent Rx Forum - Advocating for State Policy Changes
On this episode of Independent Rx Forum, Jack Mozloom from the National Community Pharmacists Association (NCPA) is joined by Joel Kurzman and Belawoe Akwakoku from the State Government Affairs Progra...
22 Aug 202329min
S1 Ep222: Pharmacy Focus: Oncology Edition - PARP Inhibitors Are Changing the Game in Prostate Cancer
This month, we spoke with Cassia Griswold, PharmD, a clinical oncology pharmacist at Mayo Clinic Arizona. Griswold discussed the latest updates from ASCO in PARP inhibitors for prostate cancer, as wel...
21 Aug 202324min
S1 Ep221: What to Know About the Approval of Lecanemab-irmb
In an interview with Pharmacy Times, Nikhil Palekar, MD, director of the Stony Brook Center of Excellence for Alzheimer Disease, director of the Stony Brook Division for Geriatric Psychiatry, and dire...
4 Aug 202317min
